| P2093 | author name string | Jürgen Aschoff | |
| | Arne May | |
| | Marek Gawel | |
| | Bruce R Charlesworth | |
| | REALIZE Study Team | |
| P2860 | cites work | The impact of migraine: Epidemiology, risk factors, and co-morbidities | Q34213804 |
| | Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study Group | Q39452008 |
| | Migraine and reduced work performance: a population-based diary study | Q44551036 |
| | The impact of migraine on quality of life in the general population: the GEM study. | Q51974172 |
| P433 | issue | 1 | |
| P921 | main subject | migraine | Q133823 |
| P304 | page(s) | 7-16 | |
| P577 | publication date | 2005-01-01 | |
| P1433 | published in | Headache | Q5689497 |
| P1476 | title | Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study | |
| P478 | volume | 45 | |